Fertility and Sterility
Volume 79, Issue 2 , Pages 261-267, February 2003

A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels

  • R.G.V Smolders, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • M.J van der Mooren, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationReprint requests: M. J. van der Mooren, M.D., Ph.D., Department of Obstetrics and Gynecology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands (FAX: 31-20-44-44-422).
  • ,
  • T Teerlink, Ph.D.

      Affiliations

    • Department of Clinical Chemistry, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • J.M.W.M Merkus, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University Medical Center St. Radboud, Nijmegen, The Netherlands
  • ,
  • M.V.A.M Kroeks, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Diakonessenhuis, Utrecht, The Netherlands
  • ,
  • H.R Franke, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Medisch Spectrum Twente, Enschede, The Netherlands
  • ,
  • C.D.A Stehouwer, Ph.D.

      Affiliations

    • Department of Internal Medicine, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • P Kenemans, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands

Received 21 February 2002; received in revised form 10 June 2002; accepted 10 June 2002.

Abstract 

Objective

To assess the effect of transdermal vs. oral administration of E2 on plasma homocysteine levels and to evaluate the impact of adding a progestogen to these regimens.

Design

Prospective, double-blind, double-dummy, placebo-controlled study.

Setting

Outpatient clinics in two university hospitals and two teaching hospitals in The Netherlands.

Patient(s)

One hundred fifty-two healthy hysterectomized postmenopausal women.

Intervention(s)

Thirteen 28-day treatment cycles with placebo (n = 49); transdermal 17β-E2, 50 μg (n = 33), oral E2, 1 mg (n = 37), or oral E2, 1 mg, plus gestodene, 25 μg (n = 33), followed by four cycles of placebo in each group.

Main outcome measure(s)

Fasting plasma total homocysteine concentrations at baseline and cycle 4, 13, and 17.

Result(s)

Mean (±SD) homocysteine concentrations in the oral E2 group decreased from baseline to cycle 4 (9.0 ± 2.5 μmol/L vs. 8.2 ± 2.0 μmol/L; mean change, −7.6%). Homocystine values in the oral E2 plus gestodene group did not change substantially from baseline to cycle 4 (8.9 ± 1.6 μmol/L vs. 8.6 ± 2.0 μmol/L; mean change, −4.4%). No significant changes were observed in the transdermal E2 group. After four washout cycles, the homocysteine concentration had returned to baseline values in all groups.

Conclusion(s)

Oral E2 therapy reduced the homocysteine concentration more than did therapy with transdermal E2 or oral E2 plus gestodene. This finding may indicate a role of liver metabolism and suggests that gestodene has a negative effect on these changes.

Keywords:  Transdermal, hormone replacement therapy, estrogen, gestodene, homocysteine, placebo

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by research grants from the Netherlands Heart Foundation (grant 95.201), Biocare Foundation (grant 96.312), and Schering AG (Berlin, Germany, grant 96.083).

PII: S0015-0282(02)04661-7

doi:10.1016/S0015-0282(02)04661-7

Fertility and Sterility
Volume 79, Issue 2 , Pages 261-267, February 2003